Literature DB >> 22101155

Morbidly obese women with and without endometrial cancer: are there differences in measured physical fitness, body composition, or hormones?

Susan C Modesitt1, Dyanna L Geffel, Jennifer Via, Arthur L Weltman.   

Abstract

OBJECTIVE: Exercise is potentially protective against cancer for obese women. The objectives were to examine differences in activity, body composition, and hormones in overweight/obese women with and without endometrial cancer.
METHODS: Women ≥ 50 years old with a body mass index (BMI) ≥ 25 kg/m(2) scheduled for abdominal hysterectomy were enrolled. Demographics, physical activity, and quality of life (QOL) data were collected. Body composition/fitness was evaluated using Air Displacement Plethysmography (BodPod) and a standardized treadmill. Adiponectin, androstenedione, leptin, estradiol, estrone, progesterone, sex hormone binding globulin, insulin and glucose were measured.
RESULTS: Thirty-eight women enrolled in this pilot study; 22 had endometrial cancer. Mean age was 58.3 years, mean BMI, fat weight and percent body fat were 41.3 kg/m(2), 55 kg and 51% respectively. Fitness levels were poor; 90% of women had peak oxygen uptakes below the 10th percentile of population normals yet 80% still rated their fitness level as equivalent to other women. Women with and without cancer did not differ in age, BMI, co-morbidities, energy expenditures, body composition, hormones or QOL although glucose levels were higher in women with cancer (119.5 vs. 90.7 mg/dl; p=0.049). Cancer subjects scored worse on every fitness measurement, reaching statistical significance for VO(2 peak) (15.0 vs. 17.9 ml/kg/min; p=0.033). Current exercisers had a lower BMI (p=0.039), decreased fat weight (p=0.024), decreased waist circumference (p=0.05) and improved vitality compared to non-exercisers.
CONCLUSION: Physical fitness levels were abysmal in these morbidly obese subjects and worse for cancer patients. Exercise correlated with improved body composition and vitality.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101155     DOI: 10.1016/j.ygyno.2011.11.013

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

1.  Recruiting Endometrial Cancer Survivors to Studies Examining Lifestyle Behaviors and Quality of Life: Challenges Faced and Lessons Learned.

Authors:  Alexander R Lucas; Brian C Focht; David E Cohn; Maryanna D Klatt; Janet Buckworth
Journal:  J Cancer Educ       Date:  2018-08       Impact factor: 2.037

2.  Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): a randomized trial in obese endometrial cancer survivors.

Authors:  Nora L Nock; Anastasia Dimitropoulos; Stephen M Rao; Chris A Flask; Mark Schluchter; Kristine M Zanotti; Peter G Rose; John P Kirwan; Jay Alberts
Journal:  Contemp Clin Trials       Date:  2014-08-17       Impact factor: 2.226

Review 3.  Quantifying the Effect of Physical Activity on Endometrial Cancer Risk.

Authors:  Sarah J Kitson; Olivia Aurangzeb; Jawaria Parvaiz; Artitaya Lophatananon; Kenneth R Muir; Emma J Crosbie
Journal:  Cancer Prev Res (Phila)       Date:  2022-09-01

4.  Single nucleotide polymorphism of SREBF-1 gene associated with an increased risk of endometrial cancer in Chinese women.

Authors:  Chun-Ping Qiu; Qing-Tao Lv; Samina Dongol; Chenguang Wang; Jie Jiang
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 5.  Obesity, diet, physical activity, and health-related quality of life in endometrial cancer survivors.

Authors:  Dimitrios A Koutoukidis; M Tish Knobf; Anne Lanceley
Journal:  Nutr Rev       Date:  2015-04-07       Impact factor: 7.110

6.  Construction and comprehensive analysis of the competing endogenous RNA network in endometrial adenocarcinoma.

Authors:  Chong Feng; Lei Cui; Zhen Jin; Lei Sun; Xiaoyan Wang; Xinshu Chi; Qian Sun; Siyu Lian
Journal:  BMC Genom Data       Date:  2022-02-06

7.  Circulating adiponectin levels and risk of endometrial cancer: Systematic review and meta-analysis.

Authors:  Zhi-Jun Li; Xue-Ling Yang; Yan Yao; Wei-Qing Han; B O Li
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

Review 8.  The Role of Hyperglycemia in Endometrial Cancer Pathogenesis.

Authors:  Frances L Byrne; Amy R Martin; Melidya Kosasih; Beth T Caruana; Rhonda Farrell
Journal:  Cancers (Basel)       Date:  2020-05-08       Impact factor: 6.639

Review 9.  Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies.

Authors:  Satoru Kyo; Kentaro Nakayama
Journal:  Int J Mol Sci       Date:  2020-08-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.